Piramal Pharma Ltd.

₹218

-8.6 (-3.8%)

PPLPHARMA Share Price

Pharmaceuticals & Biotechnology

As on September 9, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 29,926 Cr

P/E Ratio-92.28

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	218.6	Bearish
10-DMA	216.8	Bullish
20-DMA	213.63	Bullish
50-DMA	197.99	Bullish
100-DMA	183.05	Bullish
200-DMA	172.42	Bullish

Historical Performance

1 Year

13.9%

3 Years

114.3%

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	88,691	91,512	81,712	70,815	65,591
Total Expenditure	79,766	77,333	70,006	64,533	56,094
Other Income	2,424	1,618	2,011	2,251	2,758
Operating Profit	11,349	15,796	13,717	8,533	12,255
Interest	3,408	4,216	4,485	3,442	1,982
Depreciation	8,312	8,163	7,406	6,767	5,862
Profit Before Tax	-1,761	4,146	1,793	-1,202	4,850
Consolidated Net Profit	-3,259	911	178	-1,865	3,760
Adjusted EPS	-2	1	---	-2	3

Compounded Sales Growth

10 Years:7

5 Years:7

3 Years:4.6

TTM:-0.6

Compounded Profit Growth

10 Years:-33

5 Years:-33

3 Years:11.8

TTM:4.4

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:27.3

TTM:9.4

Return on Equity

10 Years:N/A

5 Years:3.1

3 Years:0.1

last year:-2.5

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	13,272	13,243	13,229	11,933	11,859
Total Reserves	67,627	67,390	65,610	55,802	55,107
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	45,294	33,927	26,446	38,120	29,026
Other Current Liabilities	14,786	11,847	15,757	13,053	12,428
Short Term Borrowings	7,478	9,953	11,714	13,023	6,588
Total Liabilities	1,75,668	1,53,688	1,49,253	1,44,365	1,27,172
Capital Work in Progress	7,992	4,891	5,657	8,529	6,732
Long Term Loans & Advances	1,552	911	1,148	4,940	2,970
Currents Investments	1,318	196	1,447	4,271	504
Short Term Loans and Advances	5,858	5,632	4,450	4,879	5,048
Total Current Assets	73,081	58,813	54,645	48,435	41,519
Total Assets	1,75,668	1,53,688	1,49,253	1,44,365	1,27,172
Adjusted Book Value	61	61	60	55	55

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of -92.28, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 29.2%, indicating sustained price appreciation.
The stock carries a beta of 1.1, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹11349 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹88691 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1094377.5

No. of Shares: 5020 (Approx)

Performance:9.4%

94377.5

NIFTY Performance: -6.2%

1 day Top Gainers